News|Articles|June 18, 2001

New Product Newswire

New Products for 6b issue

 

NEW PRODUCT NEWSWIRE

Rx

NEW DRUGS

Aventis' Lantus (insulin glargine [rDNA origin] injection) is now available. The Bridgewater, N.J., firm, (908) 243-6000, claims that Lantus is the first and only insulin analog that lowers glucose for 24 hours with once-a-day administration. The long-acting insulin, indicated for subcutaneous injection at bedtime, can be used by both type 2 (adult) and type 1 (adult and pediatric) diabetes patients. Lantus must not be mixed or diluted with any other insulin or solution, or the onset of action and time to peak effect may be affected.

Internal server error